索非那新琥珀酸盐 T0111

Product Introduction
Bioactivity


英文名: Solifenacin succinate

描述: Solifenacin succinate (YM905) 是毒蕈碱受体拮抗剂，对 M1、M2和M3受体的pKi 值分别为 7.6、6.9 和 8.0。

体内活性: Solifenacin succinate是一种新型毒蕈碱受体拮抗剂,用于治疗膀胱过度活动症。Solifenacin与奥昔布宁联用,在豚鼠上分离出的膀胱平滑肌细胞和小鼠上分离出的颌下腺细胞中,可以抑制毒蕈碱受体M3介导的细胞内钙离子的调动。

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 25 mg/mL (52.02 mM)


关键字: inhibit | YM-905 | Muscarinic acetylcholine receptor | YM 905 | Inhibitor | Solifenacin | Solifenacin succinate | Solifenacin Succinate | mAChR

相关产品: KH7 | (-)-OPC-51803 | AChE/BChE-IN-10 | Nicardipine hydrochloride | Asoxime dichloride | Pozanicline hydrochloride | Tiotropium Bromide hydrate | UB 165 fumarate | Clidinium bromide | Ursulcholic acid

相关库: Drug Repurposing Compound Library | Anti-Neurodegenerative Disease Compound Library | Approved Drug Library | FDA-Approved & Pharmacopeia Drug Library | Clinical Compound Library | Membrane Protein-targeted Compound Library | Bioactive Compounds Library Max | Neuronal Signaling Compound Library | Inhibitor Library | Bioactive Compound Library

索非那新琥珀酸盐 T0111信息由TargetMol中国为您提供，如您想了解更多关于索非那新琥珀酸盐 T0111报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途